Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Glucocorticoids for Acute Osteoarthritis Pain in the ED
NCT06603662Phase 4Recruiting
- Sponsor
- WellSpan Health
- Start
- Feb 2025
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in osteoarthritis (OA) comparing Control - Placebo, Intervention A - Prednisone and Intervention B - Dexamethasone (3 arms). Primary endpoints: Change in Resting Pain Score at 3 days and Adverse Events at 28 days. Started Feb 2025; status: recruiting.
02
Drugs
prednisonedexamethasone
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06603662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06603662.